Literature DB >> 19889118

Maculopapular eruption to rivastigmine's transdermal patch application and successful oral desensitization.

M Makris1, S Koulouris, I Koti, X Aggelides, D Kalogeromitros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19889118     DOI： 10.1111/j.1398-9995.2009.02258.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  4 in total

Review 1.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

2.  An atypical cutaneous reaction to rivastigmine transdermal patch.

Authors:  T Grieco; M Rossi; V Faina; I De Marco; P Pigatto; S Calvieri
Journal:  J Allergy (Cairo)       Date:  2011-01-11

Review 3.  Contact dermatitis due to transdermal therapeutic systems: a clinical update.

Authors:  Paolo Romita; Caterina Foti; Gianfranco Calogiuri; Stefania Cantore; Andrea Ballini; Gianna Dipalma; Francesco Inchingolo
Journal:  Acta Biomed       Date:  2018-10-26

4.  Acquired Localized Hypertrichosis Induced by Rivastigmine.

Authors:  Adrian Imbernón-Moya; Sebastian Podlipnik; Fernando Burgos; Elena Vargas-Laguna; Antonio Aguilar-Martínez; Eva Fernández-Cogolludo; Miguel Angel Gallego-Valdes
Journal:  Case Rep Dermatol Med       Date:  2016-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.